Immunomodulatory antibody therapy of Cancer: The closer, the better

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Immune checkpoint blockade therapies have demonstrated promising therapeutic effects; however, clinical outcomes are variable, with only a subgroup of cancer patients achieving durable complete responses. New therapeutic strategies, including local administration of immunomodulatory antibodies, have been considered as better routes for improving the overall efficacy of antibody-based therapy.

Original languageEnglish (US)
Pages (from-to)944-946
Number of pages3
JournalClinical Cancer Research
Issue number5
StatePublished - Mar 1 2015

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Immunomodulatory antibody therapy of Cancer: The closer, the better'. Together they form a unique fingerprint.

Cite this